62037-700 : 24 Hr Taztia 360 mg Extended Release Capsule


NDC62037-700
Labeler: Watson Pharma, Inc.
Product Type: Human Prescription Drug
Drug Name:  Taztia Xt
Dosage Form: Oral Capsule, Extended Release
Application #: ANDA075401
Rev. Date: 


Appearance:


Markings: Andrx;700;360;mg
Shapes:  Capsule
Colors:  Blue / Blue
Size (mm): 23
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Andrx 700 360 mg: (62037-700) 24 Hr Taztia 360 mg Extended Release Capsule by Watson Pharma, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 62037-700-05: 500 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (62037‑700‑05)
  • 62037-700-10: 1000 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (62037‑700‑10)
  • 62037-700-30: 30 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (62037‑700‑30)
  • 62037-700-90: 90 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (62037‑700‑90)

Active Ingredients:

  • Diltiazem Hydrochloride

Dosage Strength:

  • 360 mg

Inactive Ingredients:

  • Ferrosoferric Oxide
  • Starch, Corn
  • Ethylcellulose (10 Mpa.s)
  • D&c Yellow No. 10
  • Fd&c Blue No. 1
  • Fd&c Blue No. 2
  • Fd&c Red No. 40
  • Gelatin
  • Hypromellose 2910 (5 Mpa.s)
  • Magnesium Stearate
  • Nonoxynol-100
  • Shellac
  • Polysorbate 80
  • Ethyl Acrylate and Methyl Methacrylate Copolymer (2:1; 750000 Mw)
  • Povidones
  • Propylene Glycol
  • Sucrose
  • Talc
  • Titanium Dioxide
  • Aluminum Oxide

Pharmaceutical Classes:

  • Calcium Channel Antagonists [MoA]
  • Calcium Channel Blocker [EPC]

Related Products:

Based on records with the same trade name.
  • 62037-696 24 Hr Taztia 120 mg Extended Release Capsule by Watson Pharma, Inc.
  • 62037-697 24 Hr Taztia 180 mg Extended Release Capsule by Watson Pharma, Inc.
  • 62037-698 24 Hr Taztia 240 mg Extended Release Capsule by Watson Pharma, Inc.
  • 62037-699 24 Hr Taztia 300 mg Extended Release Capsule by Watson Pharma, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 62037-700 QR Code

< Prev: 62037-699Next: 62037-710 >

Related Discussions:

Diltiazem xt 180 mg
Has anyone had the reddening of the skin due to peripheral vaso dilation, if so when med. Was discontinued did it subsid... 5 replies
Diltiazem Hydrochloride Extended Release Capsules
not sure ## How long does it take for diltiaXT180mg to leave your system and side effects to subside? ## My doctor start... 6 replies
diltiazem er/xr and cartia xt
Is there a difference between these 2 meds I was on diliazem 120 er/xr for 4 years and had no problems and now the med w... 2 replies
extended release capsules diltiazem 240 mg
Is it normal to have 4 little white pills inside the capsules? When my friend was taking her meds she found little white... 1 reply
Compare Diltiazem ER 180mg XT cap to two Diltiazem 90mg tablets @ 12hr intervals.
My new pharmacy plan puts my Diltiazem ER 180mg XT capsule into a Tier 3 costing me $60 for a 90 day supply. A tier 1 or... 1 reply
Diltiazem hcl sa caps 180mg vs Carti XT caps 180mg
I use to take Cardizem cd 180mg. I have lots of trouble with generics. I was switched to Diltiazem hcl sa caps some time... 2 replies
What Is The Difference Between Diltiazem Xt And Cd
My prior prescription said I could take without regard to food. The new one said take on an empty stomach. Both are 180 ... 2 replies
Diltiazem CD, XR & ER
What is the difference between diltiazem CD, diltiazem XR and diltiazem ER? Can you refer me to a website where I could ... 74 replies
diltiazem cd er
I have been told by my Neurologist that this drug Diltiazem cd can cause Parkinson like symptoms in a small group of peo... 8 replies
Diltiazem (inwood)
Im taking diltiazem (inwood)240 mg sa cap and im having something like a rash on my face and my eyes have been bothering... 8 replies




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 January 2017.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA